Health – Google News Pfizer: Talks With FDA Continue on Breast-Cancer Drug – Wall Street… http://bit.ly/1FuIonc http://bit.ly/1HVtcgv

-
Health – Google News Pfizer: Talks With FDA Continue on Breast-Cancer Drug – Wall Street… http://bit.ly/1FuIonc http://bit.ly/1HVtcgv

http://bit.ly/1HVteoE Health – Google News Pfizer: Talks With FDA Continue on Breast-Cancer Drug – Wall Street… http://bit.ly/1FuIonc http://bit.ly/1HVtcgv

Comments

Post a Comment

Popular posts from this blog

CHPSRE"To Rondeau" / A modest proposal to add verb describing maritime whistleblower reprisal to the popular debate https://bit.ly/3cU3DBr via @academia http://twitter.com/CHPSRE/status/1254990181205069825

-
"To Rondeau" / A modest proposal to add verb describing maritime whistleblower reprisal to the popular debate https://t.co/YHoD7dXmfA via @academia — 🇮🇱🇺🇸CollaborateForRights🏳‍🌈🇨🇦🇫🇷🇬🇧🇬🇷 (@CHPSRE) April 28, 2020 from Twitter https://twitter.com/CHPSRE April 27, 2020 at 09:25PM via IFTTT
Read more

INTERSTELLAR OBJECT 3I/ATLAS, BLIND SPOTS IN 3I/ATLAS MONITORING (what could let a hostile craft slip through undetected)

-
────────────────────── INTERSTELLAR OBJECT 3I/ATLAS BLIND SPOTS IN 3I/ATLAS MONITORING (what could let a hostile craft slip through undetected) Comprehensive Threat & Opportunity Brief Version 1.0  30 July 2025 ────────────────────── 1. Executive Summary • Object: 11 km interstellar comet on hyperbolic trajectory. • Closest Earth approach: 1.8 AU (270 million km) on 19 Dec 2025. • Current Bayesian posterior for any non-natural origin: 0.04 % (1 in 2 500). • Critical observation window: 21 Nov – 5 Dec 2025 (Sun-occult manoeuvre). • Decision horizon: 114 days from today. 2. Four Canonical Scenarios   Scenario Signature to Watch Likelihood Human Response  Natural Comet Normal dust, red slope, no Δv 99.96 % Scientific study only  Hostile Sterilizer Sudden Δv ≥ 1 km s⁻¹, IR flare, EMP/energy beam < 0.02 % Kinetic intercept, EMP shielding, bunkers  Hostile Take-over Sub-probe release, femtosat swarms, comms chatter < 0.02 % Laser bus, cyber hardening,...
Read more